Gladstone Institutional Advisory LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1766530 Bedminster, NJ

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$295,921

+$18,048 QoQ

Shares Held

383

+6.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Gladstone Institutional Advisory LLC holds $2,203,514 across 10 Biotechnology names. REGN ranks #5 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	6,091	$573,284
2	IBRX	ImmunityBio, Inc.	51,418	$394,376
3	VKTX	Viking Therapeutics, Inc.	9,552	$310,822
4	SRPT	Sarepta Therapeutics, Inc.	13,885	$302,137
5	REGN	Regeneron Pharmaceuticals, Inc. This page	383	$295,921
6	AVXL	Anavex Life Sciences Corp.	72,381	$222,209
7	GALT	Galectin Therapeutics Inc	23,900	$66,681
8	CRDF	Cardiff Oncology, Inc.	13,000	$21,060

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$295,921	383	+6.4%	Shares	Sole	2026-05-14
2025-12-31	$277,873	360	-18.4%	Shares	Sole	2026-02-17
2025-09-30	$247,961	441	+5.5%	Shares	Sole	2025-10-22
2025-06-30	$219,450	418	-52.1%	Shares	Sole	2025-08-12
2023-09-30	$718,444	873	-0.5%	Shares	Sole	2023-11-13
2023-06-30	$630,159	877	-10.5%	Shares	Sole	2023-08-10
2022-06-30	$579,307	980	-33.4%	Shares	Sole	2023-01-30
2021-09-30	$890,219	1,471	+177.5%	Shares	Sole	2023-01-30
2020-09-30	$296,683	530	-28.2%	Shares	Sole	2023-01-30
2020-06-30	$460,253	738	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.